FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Twitter | Covance | Merck | Big Pharma

Covance and Merck deal genes; Twitter top blogs for pharma;

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

> Merck has committed to a five-year $145 million contract to purchase genomic analysis services from contract research organization Covance, which in turn is acquiring the big pharma's Gene Expression Lab, a provider of genotyping, gene sequencing and gene expression profiling. Covance release

> Nine Big Pharma companies have opted for a Twitter corporate presence over a blog. Article

> Salesforce.com is investing in electronic medical records company Practice Fusion. Article

> OmniComm Systems, an electronic data capture company that bought the EDC business of eResearch Technology in June, is now taking over the EDC assets of UK-based clinical software provider Logos Technologies. Report

> IT service provider Blue Star Infotech has implemented its NAV Elixir, a pharma-specific enterprise resource planning solution built on the Microsoft Dynamics product suite, for Indoco Remedies, a formulations and API supplier. Brief


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about Big Pharma   Twitter   Covance   Merck